Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories is set to continue its growth trajectory in the coming years, with the recent retirement of CEO Kevin Yeaman and the appointment of Marc Whitten as the new CEO. Whitten's background in product development is a clear signal of the company's focus on expanding its technology offerings beyond just audio. Despite potential challenges in the supply chain and the need to convince device manufacturers to adopt new technologies, Dolby's dominant market position, strong cash flow, and expanding adoption of Atmos and Vision in various devices provide a strong foundation for growth. The stock is currently trading at a P/E of 13.5x on CY27 EPS, and we maintain a Buy rating on the stock with a target price of $85, reflecting a 19x multiple on CY26 EPS which reflects the company's strong financials and market position.

Bears say

Dolby Laboratories is experiencing a negative outlook due to its dependence on device licensing for revenue, with its new revenue sources from VDP and OptiView still in their early stages. While management is successfully driving growth in Atmos and Vision, a general uptick in end demand is needed to excite investors. Its solid market position, strong cash flow, and growing base of licensed devices could support future growth, but current risks and uncertainties have led to a stagnant stock price.

Dolby Laboratories (DLB) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 2 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $87.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $87.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.